Skip to main content
Erschienen in: Inflammation 3/2016

08.04.2016 | ORIGINAL ARTICLE

The Effects of IL-22 on the Inflammatory Mediator Production, Proliferation, and Barrier Function of HUVECs

verfasst von: Xian He, Hui Li, Ying Chen, Aijun Chen, Kui Shan, Jin Chen, Hengguang Zhao, Xiaojiao Zhang, Tao Cai

Erschienen in: Inflammation | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate the effects of interleukin (IL)-22 on proliferation function and inflammatory mediator production and barrier function of human umbilical vein endothelial cells (HUVECs). The expression of mRNA was detected by RT-PCR. The proliferation ability of cells was evaluated using a cell counting kit assay. Real-time quantitative PCR and Western blot were used to detect the expression of inflammatory mediators. The endothelial barrier permeability was assessed by measuring permeability to FITC-labeled dextran. The distribution of occludin was detected by immunofluorescence. IL-22R1 mRNA expression was noted in HUVECs. IL-22 could enhance the proliferation ability of HUVECs and suppress lipopolysaccharide (LPS)-induced proliferation inhibition in these cells. IL-22 also enhanced the production of CCL2 and CCL20 by HUVECs. Besides, IL-22 could improve barrier function and decrease LPS-induced increased cellular permeability and inhibit the LPS-induced destruction of occludin in HUVECs. IL-22 may play a protective role in the development of vasculitis.
Literatur
1.
Zurück zum Zitat Pestka, S., C.D. Krause, D. Sarkar, et al. 2004. Interleukin-10 and related cytokines and receptors. Annual Review of Immunology 22: 929–979.CrossRefPubMed Pestka, S., C.D. Krause, D. Sarkar, et al. 2004. Interleukin-10 and related cytokines and receptors. Annual Review of Immunology 22: 929–979.CrossRefPubMed
2.
Zurück zum Zitat Kotenko, S.V., L.S. Izotova, O.V. Mirochnitchenko, et al. 2001. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rβ) is a common chain of both the IL-10 and IL-22 (IL-10-related cell-derived inducible factor, IL-TIF) receptor complexes. Journal of Biological Chemistry 276(4): 2725–2732.CrossRefPubMed Kotenko, S.V., L.S. Izotova, O.V. Mirochnitchenko, et al. 2001. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rβ) is a common chain of both the IL-10 and IL-22 (IL-10-related cell-derived inducible factor, IL-TIF) receptor complexes. Journal of Biological Chemistry 276(4): 2725–2732.CrossRefPubMed
3.
Zurück zum Zitat Tachiiri, A., R. Imamura, Y. Wang, et al. 2003. Genomic structure and inducible expression of the IL-22 receptor α chain in mice. Genes and Immunity 4(2): 153–159.CrossRefPubMed Tachiiri, A., R. Imamura, Y. Wang, et al. 2003. Genomic structure and inducible expression of the IL-22 receptor α chain in mice. Genes and Immunity 4(2): 153–159.CrossRefPubMed
4.
Zurück zum Zitat Wolk, K., S. Kunz, E. Witte, et al. 2004. IL-22 increases the innate immunity of tissues. Immunity 21(2): 241–254.CrossRefPubMed Wolk, K., S. Kunz, E. Witte, et al. 2004. IL-22 increases the innate immunity of tissues. Immunity 21(2): 241–254.CrossRefPubMed
5.
Zurück zum Zitat Hammerich, L., and F. Tacke. 2014. Interleukins in chronic liver disease: lessons learned from experimental mouse models. Clinical and Experimental Gastroenterology 7: 297.PubMedPubMedCentral Hammerich, L., and F. Tacke. 2014. Interleukins in chronic liver disease: lessons learned from experimental mouse models. Clinical and Experimental Gastroenterology 7: 297.PubMedPubMedCentral
6.
Zurück zum Zitat Troncone, E., I. Marafini, F. Pallone, et al. 2013. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad. International Reviews of Immunology 32(5-6): 526–533.CrossRefPubMed Troncone, E., I. Marafini, F. Pallone, et al. 2013. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad. International Reviews of Immunology 32(5-6): 526–533.CrossRefPubMed
7.
Zurück zum Zitat Kong, Q., W. Wu, F. Yang, et al. 2012. Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-induced mice acute viral myocarditis. Virology Journal 9: 232.CrossRefPubMedPubMedCentral Kong, Q., W. Wu, F. Yang, et al. 2012. Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-induced mice acute viral myocarditis. Virology Journal 9: 232.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Scheiermann, P., M. Bachmann, I. Goren, et al. 2013. Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injury. The American Journal of Pathology 182(4): 1107–1113.CrossRefPubMed Scheiermann, P., M. Bachmann, I. Goren, et al. 2013. Application of interleukin-22 mediates protection in experimental acetaminophen-induced acute liver injury. The American Journal of Pathology 182(4): 1107–1113.CrossRefPubMed
9.
Zurück zum Zitat Ciccia, F., A. Accardo‐Palumbo, R. Alessandro, et al. 2012. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis & Rheumatism 64(6): 1869–1878.CrossRef Ciccia, F., A. Accardo‐Palumbo, R. Alessandro, et al. 2012. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis & Rheumatism 64(6): 1869–1878.CrossRef
10.
Zurück zum Zitat Hoegl, S., M. Bachmann, P. Scheiermann, et al. 2011. Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury. American Journal of Respiratory Cell and Molecular Biology 44(3): 369–376.CrossRefPubMed Hoegl, S., M. Bachmann, P. Scheiermann, et al. 2011. Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury. American Journal of Respiratory Cell and Molecular Biology 44(3): 369–376.CrossRefPubMed
11.
Zurück zum Zitat Sonnenberg, G.F., M.G. Nair, T.J. Kirn, et al. 2010. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. The Journal of Experimental Medicine 207(6): 1293–1305.CrossRefPubMedPubMedCentral Sonnenberg, G.F., M.G. Nair, T.J. Kirn, et al. 2010. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. The Journal of Experimental Medicine 207(6): 1293–1305.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Song, R.H., Z.Y. Yu, Q. Qin, et al. 2014. Different levels of circulating Th22 cell and its related molecules in Graves’ disease and Hashimoto’s thyroiditis. International Journal of Clinical and Experimental Pathology 7(7): 4024.PubMedPubMedCentral Song, R.H., Z.Y. Yu, Q. Qin, et al. 2014. Different levels of circulating Th22 cell and its related molecules in Graves’ disease and Hashimoto’s thyroiditis. International Journal of Clinical and Experimental Pathology 7(7): 4024.PubMedPubMedCentral
13.
Zurück zum Zitat Wang, P, Bai F, Zenewicz L A, et al. 2012. IL-22 signaling contributes to West Nile encephalitis pathogenesis Wang, P, Bai F, Zenewicz L A, et al. 2012. IL-22 signaling contributes to West Nile encephalitis pathogenesis
14.
Zurück zum Zitat Sonnenberg, G.F., L.A. Fouser, and D. Artis. 2010. 1 Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at Barrier surfaces. Advances in Immunology 107: 1.CrossRefPubMed Sonnenberg, G.F., L.A. Fouser, and D. Artis. 2010. 1 Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at Barrier surfaces. Advances in Immunology 107: 1.CrossRefPubMed
15.
Zurück zum Zitat Cai, T., Q. Wang, Q. Zhou, et al. 2013. Increased expression of IL-22 is associated with disease activity in Behcet’s disease. PloS One 8(3): e59009.CrossRefPubMedPubMedCentral Cai, T., Q. Wang, Q. Zhou, et al. 2013. Increased expression of IL-22 is associated with disease activity in Behcet’s disease. PloS One 8(3): e59009.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Zhou, H., X. Huang, and A. Kijlstra. 2008. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Investigative Ophthalmology & Visual Science 49(7): 3058–3064.CrossRef Zhou, H., X. Huang, and A. Kijlstra. 2008. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Investigative Ophthalmology & Visual Science 49(7): 3058–3064.CrossRef
17.
Zurück zum Zitat Rasouli, M., B. Heidari, and M. Kalani. 2014. Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease. Immunology Letters 162(1): 269–275.CrossRefPubMed Rasouli, M., B. Heidari, and M. Kalani. 2014. Downregulation of Th17 cells and the related cytokines with treatment in Kawasaki disease. Immunology Letters 162(1): 269–275.CrossRefPubMed
18.
Zurück zum Zitat Shang, W.Q., J.J. Yu, L. Zhu, et al. 2015. Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells. American Journal of Translational Research 7(10): 1782.PubMedPubMedCentral Shang, W.Q., J.J. Yu, L. Zhu, et al. 2015. Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells. American Journal of Translational Research 7(10): 1782.PubMedPubMedCentral
19.
20.
Zurück zum Zitat Zhao, Y., J. Sun, W. Dou, et al. 2015. Curcumin inhibits proliferation of interleukin-22-treated HaCaT cells. International journal of clinical and experimental medicine 8(6): 9580.PubMedPubMedCentral Zhao, Y., J. Sun, W. Dou, et al. 2015. Curcumin inhibits proliferation of interleukin-22-treated HaCaT cells. International journal of clinical and experimental medicine 8(6): 9580.PubMedPubMedCentral
21.
Zurück zum Zitat Schultze, J L, Schmieder A, Goerdt S. 2015. Macrophageactivation in human diseases[C]//Seminars in immunology. Academic Press. Schultze, J L, Schmieder A, Goerdt S. 2015. Macrophageactivation in human diseases[C]//Seminars in immunology. Academic Press.
22.
Zurück zum Zitat Tamoutounour, S., M. Guilliams, F.M. Sanchis, et al. 2013. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 39(5): 925–938.CrossRefPubMed Tamoutounour, S., M. Guilliams, F.M. Sanchis, et al. 2013. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 39(5): 925–938.CrossRefPubMed
23.
Zurück zum Zitat Wang, S., M. Xu, F. Li, et al. 2012. Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1. Breast Cancer Research and Treatment 133(3): 1037–1048.CrossRefPubMedPubMedCentral Wang, S., M. Xu, F. Li, et al. 2012. Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1. Breast Cancer Research and Treatment 133(3): 1037–1048.CrossRefPubMedPubMedCentral
24.
25.
Zurück zum Zitat Kumar, P., Q. Shen, C.D. Pivetti, et al. 2009. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Reviews in Molecular Medicine 11: e19.CrossRefPubMedPubMedCentral Kumar, P., Q. Shen, C.D. Pivetti, et al. 2009. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Reviews in Molecular Medicine 11: e19.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Yong, Y.K., H.S. Chiong, M.N. Somchit, et al. 2015. Bixa orellana leaf extract suppresses histamine-induced endothelial hyperpermeability via the PLC-NO-cGMP signaling cascade. BMC Complementary and Alternative Medicine 15(1): 356.CrossRefPubMedPubMedCentral Yong, Y.K., H.S. Chiong, M.N. Somchit, et al. 2015. Bixa orellana leaf extract suppresses histamine-induced endothelial hyperpermeability via the PLC-NO-cGMP signaling cascade. BMC Complementary and Alternative Medicine 15(1): 356.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Li, J, Cong X, Zhang Y, et al. 2015. ZO-1 and-2 Are Required for TRPV1-Modulated Paracellular Permeability. Journal of dental research: 0022034515609268. Li, J, Cong X, Zhang Y, et al. 2015. ZO-1 and-2 Are Required for TRPV1-Modulated Paracellular Permeability. Journal of dental research: 0022034515609268.
28.
Zurück zum Zitat Cabrera, G, Fernández-Brando R J, Mejías M P, et al. 2015. Leukotriene C4 increases the susceptibility of adult mice to Shiga toxin-producing Escherichia coli infection. International Journal of Medical Microbiology. Cabrera, G, Fernández-Brando R J, Mejías M P, et al. 2015. Leukotriene C4 increases the susceptibility of adult mice to Shiga toxin-producing Escherichia coli infection. International Journal of Medical Microbiology.
29.
Zurück zum Zitat Medvedev, A.E., K.M. Kopydlowski, and S.N. Vogel. 2000. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. The Journal of Immunology 164(11): 5564–5574.CrossRefPubMed Medvedev, A.E., K.M. Kopydlowski, and S.N. Vogel. 2000. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. The Journal of Immunology 164(11): 5564–5574.CrossRefPubMed
30.
Zurück zum Zitat Kim, T.H., and J.S. Bae. 2010. Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells. Food and Chemical Toxicology 48(6): 1682–1687.CrossRefPubMed Kim, T.H., and J.S. Bae. 2010. Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells. Food and Chemical Toxicology 48(6): 1682–1687.CrossRefPubMed
31.
Zurück zum Zitat Zhang, X, Wang T, Gui P, et al. 2013. Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells. Oxidative medicine and cellular longevity 2013. Zhang, X, Wang T, Gui P, et al. 2013. Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells. Oxidative medicine and cellular longevity 2013.
32.
Zurück zum Zitat Al-Sadi, R., K. Khatib, S. Guo, et al. 2011. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. American Journal of Physiology-Gastrointestinal and Liver Physiology 300(6): G1054–G1064.CrossRefPubMedPubMedCentral Al-Sadi, R., K. Khatib, S. Guo, et al. 2011. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. American Journal of Physiology-Gastrointestinal and Liver Physiology 300(6): G1054–G1064.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Alan, S.L., K.M. McCarthy, S.A. Francis, et al. 2005. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. American Journal of Physiology-Cell Physiology 288(6): C1231–C1241.CrossRef Alan, S.L., K.M. McCarthy, S.A. Francis, et al. 2005. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. American Journal of Physiology-Cell Physiology 288(6): C1231–C1241.CrossRef
34.
Zurück zum Zitat Yang, J., W.J. Kim, H.O. Jun, et al. 2015. Hypoxia-induced fibroblast growth factor 11 stimulates capillary-like endothelial tube formation. Oncology Reports 34(5): 2745–2751.PubMed Yang, J., W.J. Kim, H.O. Jun, et al. 2015. Hypoxia-induced fibroblast growth factor 11 stimulates capillary-like endothelial tube formation. Oncology Reports 34(5): 2745–2751.PubMed
35.
Zurück zum Zitat Zhang, F., X. Man, H. Yu, et al. 2015. Synergistic protective effects of escin and low-dose glucocorticoids against vascular endothelial growth factor-induced blood-retinal barrier breakdown in retinal pigment epithelial and umbilical vein endothelial cells. Molecular Medicine Reports 11(2): 1372–1377.PubMed Zhang, F., X. Man, H. Yu, et al. 2015. Synergistic protective effects of escin and low-dose glucocorticoids against vascular endothelial growth factor-induced blood-retinal barrier breakdown in retinal pigment epithelial and umbilical vein endothelial cells. Molecular Medicine Reports 11(2): 1372–1377.PubMed
36.
Zurück zum Zitat Ma, X, Zhang H, Pan Q, et al. 2013. Hypoxia/aglycemia-induced endothelial barrier dysfunction and tight junction protein downregulation can be ameliorated by citicoline. Ma, X, Zhang H, Pan Q, et al. 2013. Hypoxia/aglycemia-induced endothelial barrier dysfunction and tight junction protein downregulation can be ameliorated by citicoline.
37.
Zurück zum Zitat Sheth, P., N.D. Santos, A. Seth, et al. 2007. Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism. American Journal of Physiology-Gastrointestinal and Liver Physiology 293(1): G308–G318.CrossRefPubMed Sheth, P., N.D. Santos, A. Seth, et al. 2007. Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism. American Journal of Physiology-Gastrointestinal and Liver Physiology 293(1): G308–G318.CrossRefPubMed
Metadaten
Titel
The Effects of IL-22 on the Inflammatory Mediator Production, Proliferation, and Barrier Function of HUVECs
verfasst von
Xian He
Hui Li
Ying Chen
Aijun Chen
Kui Shan
Jin Chen
Hengguang Zhao
Xiaojiao Zhang
Tao Cai
Publikationsdatum
08.04.2016
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2016
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0341-3

Weitere Artikel der Ausgabe 3/2016

Inflammation 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.